Low-dose statin treatment increases prostate cancer aggressiveness

Prostate cancer is diagnosed late in life, when co-morbidities are frequent. Among them, hypertension, hypercholesterolemia, diabetes or metabolic syndrome exhibit an elevated incidence. In turn, prostate cancer patients frequently undergo chronic pharmacological treatments that could alter disease...

詳細記述

保存先:
書誌詳細
出版年:Oncotarget
主要な著者: Caro-Maldonado, Alfredo, Camacho, Laura, Zabala-Letona, Amaia, Torrano, Verónica, Fernández-Ruiz, Sonia, Zamacola-Bascaran, Kepa, Arreal, Leire, Valcárcel-Jiménez, Lorea, Martín-Martín, Natalia, Flores, Juana M., Cortazar, Ana R., Zúñiga-García, Patricia, Arruabarrena-Aristorena, Amaia, Guillaumond, Fabienne, Cabrera, Diana, Falcón-Perez, Juan M., Aransay, Ana M., Gomez-Muñoz, Antonio, Olivan, Mireia, Morote, Juan, Carracedo, Arkaitz
フォーマット: Artigo
言語:Inglês
出版事項: Impact Journals LLC 2017
主題:
Priority Research Paper
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5788577/
https://ncbi.nlm.nih.gov/pubmed/29416709
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.22217
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料